TransUnion (NYSE: TRU) — Cheapest-Ever Oligopoly Data at a #3 Discount, Where the Feared Score-War Is Really a Tailwind

Independent Equity Research Report date: 2026-07-04 · Price reference: $78.31 (2026-07-02)

⚡ Claude’s Take

This block is the author’s own subjective opinion and general information, not investment advice. Everything below it — the analytical body — is deliberately position-free and carries no price target.

Verdict: HOLD with a constructive bias — accumulate-on-weakness into the ~$65–72 zone (~10.5–11.5x FY26E adjusted EBITDA / ~15–17x adjusted EPS of ~$4.60); not a short here. Conviction: medium. Directional fair-value zone ~$90–100 on in-framework growth plus a partial re-rate; the bull case reaches the ~$120s only if the mortgage cycle turns.

TransUnion is the levered, lower-quality cousin of the Equifax contrarian trade, and the tape has treated it accordingly: down ~36% from its 2021 high, negative risk-adjusted returns at every horizon out to five years, a Street that is Neutral with price targets ($72–77) sitting right at spot — the fingerprint of a name quietly written off rather than actively hated. Yet the business underneath just grew revenue +9.4% (faster than Equifax’s +6.9%), printed its ninth straight quarter of high-single-digit-plus organic growth, expanded adjusted EPS to $4.30 (+10%), delevered to 2.6x, and sits at the 2.3rd percentile of its own decade’s P/E — the cheapest EV/EBITDA (~12x) in the entire data-analytics complex. The central mispricing is that the market has priced TransUnion as a structurally broken #3 when it is really an oligopoly data cooperative geared to a cyclically-depressed mortgage market — and the two most-feared threats, FICO’s Mortgage Direct License program and the FHFA’s VantageScore approval, cut the other way for the bureaus: TransUnion is a one-third owner of VantageScore, keeps its tri-merge data-pull economics regardless of which score wins, and stands to capture score-layer rents FICO monopolized for decades. A reverse-DCF says $78 embeds only ~3.5–4% perpetual growth against a demonstrated high-single-digit organic framework. The bear case is roughly at spot (~$71); the base (~$97) needs only in-framework growth at today’s multiple; the asymmetry is positive.

So why only a HOLD-with-a-bias and not a table-pound? Three things keep me honest. First, this is the crown-jewel-less #3 — unlike Equifax’s 44%-margin Work Number annuity, TransUnion has no single proprietary asset to out-earn the shared cooperative; its best differentiated leg is India/CIBIL, real and high-margin but small and FX-exposed. Second, the balance sheet has no cushion: ~$8.4B of goodwill+intangibles from the top-of-cycle 2021 Neustar/Sontiq/Argus spree leave tangible book at −$3.8B, consolidated ROIC (~6.6%) below WACC, and ~2.6x leverage on the most mortgage-cyclical earnings base of the three — a ~1.5–1.9 beta that amplifies both tails. Third, a real slice of the recent “growth” is optical: zero-margin FICO royalty pass-through (Financial Services was +24% reported but only +14% ex-FICO in Q1-26) layered on acquisition-inflated multi-year CAGRs. The framing is contrarian/value / early mean-reversion off cheapest-ever multiples — a higher-variance version of the EFX setup, not a lower-risk one. Flips decisively bullish if organic revenue holds high-single-digits into a still-weak mortgage backdrop (proving the diversified lending/fraud/marketing/India engine drives it) and leverage clears below 2.5x with FCF conversion rising as OneTru costs roll off. Flips bearish if the adjusted-EBITDA margin contracts while U.S. volumes stall (the #3 being squeezed, not cyclically depressed), or if FICO direct-licensing and bi-merge momentum visibly compress bureau mortgage economics. One tell sharpens the caution: across the Form 4 corpus, insiders logged zero open-market purchases — only routine grant/vest/sell — and own <1% of the company. Cheapest-ever, accelerating, and abandoned — but levered, crown-jewel-less, and not yet vindicated.

Tag: “The cheapest house on the bureau block — levered, un-jeweled, and just now bouncing.”

📈 Stock Price Action — Five-Year Event Map

Factual price history and attributed drivers. The price move is a Fact; the cause is Interpretation. No recommendation or price target here — that is the block above.

The arc. TransUnion has round-tripped a full cycle. From ~$85 in early 2021 it ran to an all-time high of ~$121.5 in September 2021, then de-rated with the entire high-multiple data-services complex — bottoming near ~$43 in October 2023 (a ~65% drawdown) — before a ~2.3x recovery to ~$104 in early 2025 and a renewed slide. It closed at $78.31 on 2026-07-02, roughly ~36% below its 2021 peak, inside a 52-week range of ~$63–$99, after a sharp ~+13% bounce off its March-2026 low that reclaimed the 200-day EMA (~$75.8). The market took TransUnion from growth-plus-M&A pricing (~27x EV/EBITDA) back to broken-cyclical pricing (~12x).

Cycle narrative. (1) TRU peaked in 2021 as a credit-cycle-plus-M&A growth story at ~27x EV/EBITDA just as it announced its largest-ever deals. (2) The 2022 rate shock de-rated the whole complex and hit TRU harder given its leverage and mortgage gearing. (3) A 2023 relief rally faded when (4) rates-higher-for-longer plus a $414M non-cash goodwill impairment on the U.K. (Callcredit) unit — which drove a FY23 GAAP net loss — took the stock to its ~$43 cycle trough. (5) A ~2.3x recovery followed as the OneTru technology reset and a string of beat-and-raise quarters restored confidence into early 2025. (6) That optimism unwound over 2025–early-2026 as the mortgage recovery kept slipping and the FICO/VantageScore score-war headlines took hold — even though FY25 revenue grew +9.4%. (7) The most recent leg is an oversold bounce off the cheapest valuation of TransUnion’s decade back above its 200-day EMA. Each price move is a Fact; the cyclical-versus-structural cause is the central Interpretation the body adjudicates.

1. Executive Summary

TransUnion is the third of the three U.S. national consumer credit bureaus (behind Experian and Equifax), but it is materially more than a domestic bureau: it is a global data, analytics, and identity/fraud business distinguished from its peers by a high-margin, emerging-market-led international franchise anchored on India’s CIBIL. FY2025 revenue was $4,576.3M (+9.4%), with two reporting segments: U.S. Markets ($3,578.7M gross, 78% of revenue, a 37.9% adjusted-EBITDA margin) and International ($1,011.0M gross, 22%, a richer 43.6% margin). Consolidated Adjusted EBITDA was $1,645.9M (36.0% margin); GAAP diluted EPS was $2.32 and adjusted diluted EPS $4.30 (+10%). FY26 guidance is revenue ~$5.1–5.135B (~8–9% organic) and adjusted EPS ~$4.63–4.71.

The investment question is not whether TransUnion is a good business — the tri-merge-protected bureau oligopoly and 36–44% segment margins settle that — but whether a ~36% drawdown has over-corrected a name the Street has quietly abandoned. The stock peaked near $121 in 2021 priced as a credit-cycle-plus-M&A compounder; as mortgage volumes collapsed to multi-decade lows and the market grew fearful of FICO/VantageScore disruption, it re-rated from ~27x EV/EBITDA to ~12x — the cheapest multiple in the entire data-analytics complex and the 2.3rd percentile of TransUnion’s own decade. The unusual feature, as at Equifax, is that the de-rate has occurred into improving fundamentals: nine straight quarters of high-single-digit-plus organic growth, an expanding FCF margin (8.7% → 12.3% → 14.5%), and deleveraging from 3.6x (FY23) to 2.6x.

Four things are simultaneously true. (1) The franchise is real but shared and un-jeweled — TransUnion earns oligopoly economics as one of three non-substitutable tri-merge inputs, but unlike Equifax it owns no Work Number–style proprietary annuity to out-earn the cooperative; its differentiator is India/CIBIL. (2) The feared disruption is misread — FICO’s Mortgage Direct License program and the FHFA’s July-2025 VantageScore 4.0 approval attack FICO’s score monopoly, not the bureaus’ data layer; as a one-third VantageScore owner that retains its tri-merge data pull, TransUnion is a structural winner of the scoring war. (3) The returns are dragged below WACC by 2021 M&A, not by weak economics — ~$8.4B of goodwill+intangibles from the top-of-cycle Neustar/Sontiq/Argus deals leave consolidated ROIC at ~6.6% and tangible book at −$3.8B, even as the underlying bureau is capital-light and high-return. (4) The growth print is partly optical — a slice of Financial Services “growth” is zero-margin FICO royalty pass-through, and multi-year CAGRs are acquisition-inflated. Against all of this, the market is pricing perpetual low-single-digit growth. The valuation embeds the bear case; the body that follows adjudicates whether that pessimism is warranted.

2. Business Overview

TransUnion (NYSE: TRU; CIK 0001552033; incorporated in Delaware; headquartered in Chicago; fiscal year ends December 31) is the third of the three U.S. national consumer credit bureaus, but it is more accurately described as a global data, analytics, and identity/fraud business with a fast-growing emerging-markets footprint. FY25 revenue was $4,576.3M, up 9.4% (FY24 $4,183.8M, +9.2%; FY23 $3,831.2M) (FACT — 10-K FY25, MD&A “Results of Operations”). Consolidated Adjusted EBITDA was $1,645.9M (+9.3%) at a 36.0% margin (FACT — 10-K non-GAAP reconciliation, p.65). Revenue is overwhelmingly transactional and subscription-based, monetized as per-transaction “pulls” and analytic/decisioning subscriptions on proprietary data — recurring in the embedded-usage sense, but cyclically geared to credit, lending, and (especially) mortgage volumes rather than contractually recurring like SaaS.

A structural note that runs through the whole memo: TransUnion now reports only TWO segments — U.S. Markets and International (plus a Corporate cost center) (FACT — 10-K Item 1; Note 18). The “Consumer Interactive” business that older write-ups treat as a third segment is no longer standalone; it is now a vertical inside U.S. Markets. Comparisons that name Consumer Interactive as a peer segment are stale.

U.S. Markets — the domestic engine (78% of gross revenue). FY25 gross revenue $3,578.7M (+10.5%), with segment Adjusted EBITDA of $1,356.6M at a 37.9% margin (38.1% FY24) (FACT — 10-K p.54). Three verticals:

• Financial Services — $1,684.6M (+17.5%), the growth leader. Credit and analytics sold to banks, credit unions, auto lenders, mortgage lenders, card issuers, fintechs, and consumer lenders; it includes the mortgage tri-merge credit report, auto, card & banking, and consumer lending. The FY25 +17.5% was driven “primarily by increased pricing” in mortgage plus price/volume in auto and consumer lending — and a large slice is zero-margin FICO royalty pass-through (FACT — 10-K p.54; see the Growth section).
• Emerging Verticals — $1,318.8M (+8.5%), the diversification leg: Insurance, Technology/Retail & E-Commerce, Telecommunications, Media, Tenant & Employment Screening, Collections, and Public Sector (FACT — 10-K p.54). Here TransUnion competes vertical-by-vertical against Verisk (insurance), LexisNexis, and niche players.
• Consumer Interactive — $575.3M (−2.3%), the direct-to-consumer (DTC) line: paid and free credit reports/scores/freezes, credit monitoring, identity-theft protection and breach-response, sold through TransUnion’s own sites and affinity/partner channels. It is a lower-quality, competitively contested, secularly soft line (against LifeLock and free-credit websites) and was the only U.S. vertical that shrank in FY25 (FACT — 10-K Item 1).

International — the differentiator (22% of gross revenue, and higher-margin than domestic). FY25 gross revenue $1,011.0M, with segment Adjusted EBITDA of $440.5M at a 43.6% margin — richer than U.S. Markets’ 37.9% (FACT — 10-K p.54). This is a genuine point of distinction from Equifax, whose International segment is its weakest leg (~13% margin); for TransUnion, International is a high-margin growth franchise. FY25 regional mix: UK $269.7M (+18.4%), India/CIBIL $264.2M (−1.9% reported — purely FX; strong local-currency), Canada $167.0M (+8.2%), Latin America $135.4M (+0.5%), Asia-Pacific $100.5M (−4.9%), Africa $74.1M (+11.7%) (FACT — 10-K p.54). TransUnion CIBIL — India’s first consumer and business bureau (founded 2001) and operator of the country’s most widely used credit score — is the crown-jewel international asset and a rare position where TransUnion is #1, not #3, in a large secular-growth credit economy (FACT/INTERPRETATION — 10-K Item 1).

End markets span financial services (the largest), insurance, tenant/employment screening, public sector, media/marketing, telecom, collections, and DTC. The business model is proprietary credit and identity databases monetized per-transaction and via analytics/decisioning subscriptions, delivered through the unified “OneTru” data/identity/AI platform (built on the acquired Neustar OneID architecture) (FACT — 10-K Item 1).

Verdict: a high-quality, diversified information-services company anchored by a #3-of-three U.S. bureau position, distinguished from its domestic peers by a high-margin, fast-growing international franchise (led by India/CIBIL) and a fraud/identity + marketing layer (ex-Neustar). Unlike Equifax, it has no Work Number–equivalent verification annuity — it is a “purer” bureau plus international plus DTC plus fraud/marketing story, with higher revenue growth than Equifax, lower absolute scale, and more leverage. To understand TransUnion is to weigh a shared oligopoly moat against the absence of a single differentiated jewel.

3. Industry Dynamics

TransUnion operates across the two industry structures that define the sector, and the framing carries directly from the Equifax peer analysis, restated here as TransUnion’s.

(A) The U.S. credit-bureau oligopoly (U.S. Markets). The U.S. consumer-credit data layer is a durable three-firm oligopoly — Experian, Equifax, TransUnion — with more than 90% of U.S. adults holding files at all three. Its defensibility is a textbook Greenwald economies-of-scale + regulatory-barrier moat: U.S. lenders voluntarily furnish loan and payment data to all three bureaus, creating a self-reinforcing data cooperative no entrant can replicate (you cannot will a national credit file into existence), and Fair Credit Reporting Act (FCRA) compliance is itself a barrier to entry (INTERPRETATION, Greenwald framework). Critically, every conforming U.S. mortgage requires a tri-merge report pulling all three bureaus, making TransUnion a non-substitutable input on the highest-value transaction in the system regardless of its #3 market share (FACT). TransUnion’s 10-K names its U.S. competitors as Equifax, Experian, and LexisNexis, plus FICO in scoring, Verisk in insurance, LiveRamp/Experian in marketing, and LifeLock in DTC (FACT — 10-K Item 1).

The VantageScore/FICO dynamic — a structural tailwind, not the threat the tape fears. TransUnion is one of three equal owners of the VantageScore joint venture. The FHFA’s July-8-2025 approval of VantageScore 4.0 for conforming mortgages ended Fair Isaac’s de-jure score monopoly, and it helps the bureaus two ways: any VantageScore share gain captures score-layer economics FICO previously monopolized (VantageScore priced ~$1 vs FICO’s mortgage-score journey toward ~$10), while the tri-merge data-pull requirement is retained, protecting each bureau’s underlying data revenue regardless of which score wins (INTERPRETATION). The bureaus own both the uncontested data layer and the rival score — they are the structural winners of the scoring war. The flip side is real and must be netted: FICO’s October-2025 Mortgage Direct License Program, which lets tri-merge resellers calculate FICO scores directly and threatens the bureaus’ historical markup on the FICO royalty, and FICO’s steep per-score price increases that flow through TransUnion’s P&L at zero margin. In Q1-26 FICO royalties were a 120bps drag on the adjusted-EBITDA margin and the reason Financial Services printed +24% reported but only +14% ex-FICO (FACT — Q1-26 transcript). Any honest read of “growth” strips this out — but the net structural effect of the score-war on the bureaus is neutral-to-positive on the protected data layer, not the catastrophe the headlines imply.

(B) International bureau structures. Outside the U.S., the sector is a patchwork of national bureau oligopolies at different maturities, where TransUnion competes “generally with Equifax and Experian directly or indirectly” (FACT — 10-K Item 1). In India, CIBIL is the market-leading bureau (first-mover since 2001, most-used score) — a large secular-growth credit economy where TransUnion is #1. The UK (+18.4% FY25), Canada (a two-bureau market with Equifax), Africa (South-Africa-led), Latin America, and Asia-Pacific round out a portfolio structurally more attractive than Equifax’s International because it is anchored by a high-margin emerging-market leader, not sub-scale developed-market challengers. Regulation is tightening abroad too — India’s DPDPA imposes fiduciary obligations, 72-hour breach notification, and retention limits on CIBIL (FACT — 10-K Item 1).

Regulatory landscape. The governing U.S. regime is the FCRA, supervised by the CFPB (plus the FTC and state AGs), with a private right of action and fee-shifting that makes the sector a class-action magnet (FACT/INTERPRETATION). This is double-edged — it entrenches incumbents while capping conduct and inviting enforcement — and TransUnion has a history of consumer-protection actions (2017 CFPB consent order; a 2022 CFPB “dark patterns” suit that drove a $30M Q1-22 charge; a 2023 TransUnion Rental Screening consent order with the CFPB and FTC). A GSE shift from tri-merge to bi-merge mortgage reporting — allowing fewer than three bureau pulls per loan — is a named forward risk that would mechanically remove one bureau’s pull per conforming mortgage (FACT — 10-K risk factors).

Capital-cycle (Marathon) lens. Data oligopolies are exactly the durable high-return niches that resist new capital, because the cooperative cannot be purchased (INTERPRETATION, Marathon framework). The visible supply-side pressures are: (1) the FICO scoring-share contest (net positive for the bureaus); (2) consumer-permissioned/open-banking data rails (Plaid, Argyle, cash-flow underwriting) that could, over time, route around traditional bureau pulls at the analytic edge of some lending decisions; and (3) mortgage-cycle mean reversion — U.S. mortgage inquiry volumes remain >50% below the 2015–19 average (FACT, mortgage-market data). The last is cyclical, not structural.

Verdict: a structurally good industry — a regulated bureau oligopoly with a non-replicable data cooperative, tri-merge-protected revenue, recurring transactional economics, and a genuine international growth avenue. For TransUnion specifically the industry is more favorable than for Equifax on one axis — its International exposure is a high-margin emerging-market bureau (India), not a drag — but the sector carries pronounced U.S.-mortgage cyclicality, intensifying CFPB/privacy scrutiny, and emerging consumer-permissioned-data competition. The much-feared FICO/VantageScore “disruption” is, on balance, a tailwind to the protected data layer that the market has mistaken for an existential threat.

4. Competitive Position

Name the moat: TransUnion holds an economies-of-scale + regulatory-barrier position in a data cooperative — the same mechanism as its two peers, but as the #3 by U.S. scale. As one of three national bureaus feeding every tri-merge mortgage, TransUnion sits behind a structural, non-substitutable data barrier with near-zero incremental cost per pull (INTERPRETATION, Greenwald taxonomy). The financial proof the moat is real is the margin structure: 37.9% U.S. Markets and 43.6% International segment Adjusted EBITDA margins, 36.0% consolidated (FACT — 10-K p.54) — franchise-grade economics on a data product, comparable to Experian (~37%) and above Equifax’s consolidated ~30–31%.

The critical pressure-test: is the sub-scale #3 structurally squeezed? The evidence says not materially — the bureau cooperative shares its economics across all three oligopolists. TransUnion grew revenue +9.4% in FY25, faster than Equifax (+6.9%), posted its ninth consecutive quarter of at least high-single-digit organic constant-currency growth in Q1-26 (+11% organic; +7% ex-FICO), and its 36% consolidated margin is peer-competitive (FACT — 10-K; Q1-26 transcript). The tri-merge requirement means a mortgage lender must buy TransUnion’s file, so #3 scale does not translate into share loss on the anchor transaction. Being #3 in a three-firm data cooperative is a far better position than being #3 in a normal competitive market, because the product is non-substitutable and the data cannot be replicated at any scale below national.

But the #3 position is genuinely disadvantaged on three axes (INTERPRETATION):

1. No verification crown jewel. TransUnion has no equivalent of Equifax’s The Work Number — the proprietary payroll-fed income/employment database that earns Equifax a ~44% verification margin and lifts its best segment above the bureau baseline. TransUnion’s highest-margin leg is International (India/CIBIL), which is smaller and FX-exposed. It therefore has less pricing and mix optionality than Equifax and a lower ceiling on blended returns.
2. Sub-scale in analytics/adjacencies. In marketing (TruAudience vs LiveRamp/Experian) and fraud/identity (TruValidate vs LexisNexis and specialists), TransUnion competes from a challenger position; the Neustar assets are being integrated via OneTru to close the gap but are not category leaders.
3. More leverage, less cushion. Net debt is $4,250.2M at ~2.6x Adjusted EBITDA — comparable to Equifax’s ~2.7x but on a smaller, more mortgage-cyclical earnings base, with negative tangible book (−$3.8B) from ~$8.4B of goodwill+intangibles.

On the “sub-WACC ROIC disproves the moat” objection — the same rebuttal as Equifax. Consolidated returns look mediocre: ROIC.ai puts FY25 ROIC at ~6.6% and ROE at 17.9% — the ROIC below a reasonable ~8–9% WACC. But this is almost entirely a goodwill artifact, not weak unit economics: goodwill ($5,259.5M) + other intangibles ($3,098.5M) = ~75% of $11.1B total assets. Strip the acquired intangibles and the underlying bureau franchise is capital-light and high-return — 36% adjusted-EBITDA margins, capex ~7% of revenue, incremental operating margin ~33% in FY25, on tangible invested capital of only ~$1.3B. The correct test is segment economics — 37.9% U.S. / 43.6% International EBITDA margins on near-zero-incremental-cost data — which are unambiguously franchise-grade. The consolidated ROIC ≈ WACC is the bill for richly-priced 2021 M&A, the identical pattern to Equifax.

Head-to-head — TransUnion vs Experian vs Equifax:

• Experian is the largest and most diversified (bureau + the most-developed international + a large DTC business + B2B software), the capital-efficiency leader (ROE ~27%), and the one replicating Equifax’s verification playbook. It is the quality/scale premium name.
• Equifax is #1/#2 in the U.S. and owns the verification crown jewel (The Work Number) — the highest-margin single asset in the group — but its International is weak and it is the most U.S.-mortgage-levered.
• TransUnion is #3 by U.S. scale but arguably has the best International franchise of the three (India/CIBIL leadership + a 43.6% segment margin), a credible fraud/identity + marketing layer (Neustar), and the fastest recent revenue growth — offset by the absence of a verification annuity and higher relative leverage.

Verdict: a durable competitive advantage, not a squeezed also-ran — but a narrower and more leveraged one than Equifax’s. The bureau data cooperative + tri-merge + FCRA barrier is a genuine wide-moat structure that protects TransUnion’s core revenue regardless of its #3 U.S. rank, and its India/CIBIL position is a real, high-margin, hard-to-replicate franchise. The advantage is real and shared — all three bureaus earn oligopoly economics — but TransUnion lacks the single proprietary asset (a Work Number equivalent) that would let it out-earn the cooperative, and it carries the most cyclicality-per-dollar-of-earnings of the three. Durable, yes; differentiated to the upside, only in India.

5. Growth History and Forward Opportunities

The historical record — Neustar-inflated headline growth over a genuine mid-single-digit organic core. Revenue compounded from $2,530.6M (FY20) to $4,576.3M (FY25), a ~12.6% five-year CAGR — but that number is flattered by the ~$3.1B Neustar acquisition (closed December 2021) plus Sontiq, Argus, Monevo (2025), and the pending TU Mexico deal (FACT — 10-K Item 1; ROIC.ai). The organic path was choppier: the FY21 jump to $2,960.2M and FY22 $3,709.9M included the Neustar consolidation; then FY22–23 was the trough — the rate shock collapsed mortgage volumes and TransUnion posted a FY23 GAAP net loss (the $414M U.K. goodwill impairment plus the mortgage depression), with organic growth stalling to low-single-digits (FACT — 10-K FY23). The FY24–25 reacceleration is the current story: +9.2% (FY24) and +9.4% (FY25) reported, with U.S. Markets recovering to +8%-then-+10.5% and International reaccelerating.

Segment growth detail (FY25): U.S. Markets +10.5%, led by Financial Services +17.5% (mortgage pricing + auto/consumer-lending volume) and Emerging Verticals +8.5%; Consumer Interactive −2.3% (the soft DTC leg). International — UK +18.4%, Africa +11.7%, Canada +8.2%, LatAm +0.5%, India −1.9% reported (FX only), Asia-Pacific −4.9% (FACT — 10-K p.54).

The mortgage swing factor — and the FICO pass-through that inflates it. As with Equifax, U.S. mortgage is a high-margin, cyclically depressed slice of Financial Services (roughly low-double-digits % of total revenue — below Equifax’s ~20% (INTERPRETATION/OPEN — exact figure undisclosed)), with inquiry volumes >50% below the 2015–19 norm. TransUnion has bridged the volume hole with price — but a large part of the reported mortgage growth is zero-margin FICO royalty pass-through. In Q1-26, Financial Services grew +24% reported but only +14% ex-FICO, and FICO royalties were a 120bps headwind to the adjusted-EBITDA margin (35.2%, down 100bps YoY) (FACT — Q1-26 transcript). The genuine, high-margin option value is a mortgage-volume normalization if/when rates fall — management flagged a brief Feb-2026 refi pickup that faded — but this is upside, not baked into guidance.

Forward opportunities (treated as upside, not baseline):

1. OneTru / AI-driven data usage. The unified OneTru platform (built on Neustar OneID) is TransUnion’s answer to the EFX.AI narrative — management framed Q1-26 around “AI accelerating innovation… and driving higher data usage among some clients,” citing TruIQ analytics, alternative data, and non-credit solutions as drivers of the Financial Services outperformance (FACT — Q1-26 transcript). It is also the completion vehicle for the multi-year operating-model transformation (~$120–140M annual run-rate savings, completed end-2025).
2. India and emerging markets. India/CIBIL is a secular double-digit local-currency grower (softening to mid-single-digits in 2026 on subdued lending, expected to reaccelerate); plus UK strength and the pending TU Mexico majority-stake acquisition (added ~$154M to the guide high end) extending the LatAm footprint (FACT — Q1-26 transcript; 10-K).
3. VantageScore mortgage conversion — as a one-third JV owner, TransUnion shares in any score-layer share shift (upside, not in guidance) (INTERPRETATION).
4. Fraud/identity and marketing (TruValidate/TruAudience) — the Neustar-derived adjacencies, plus the Dec-2025 RealNetworks mobile-AI acquisition, extend beyond the core bureau into higher-growth identity/communications analytics (FACT — 10-K Item 1).

Forward framework. Management is maintaining FY26 guidance of ~8–9% organic constant-currency growth (revenue ~$5.1–5.135B, adjusted EPS ~$4.63–4.71) after a Q1-26 beat (+11% organic), explicitly holding rather than raising on macro/rate caution — the same beat-and-hold posture the market punished at Equifax (FACT — Q1-26 transcript). This would be TransUnion’s third consecutive year of high-single-digit-plus organic growth.

Verdict: the growth is real but of mixed quality, and its reported rate overstates the organic, margin-bearing rate. The durable core — bureau data + India/CIBIL + Emerging Verticals + OneTru-driven new products — is compounding at a genuine mid-to-high-single-digit organic clip (proprietary data, pricing power, recurring usage), which is high-quality. But three caveats lower the quality of the headline: (1) a meaningful slice of recent Financial Services “growth” is zero-margin FICO pass-through; (2) the multi-year CAGR is acquisition-inflated; and (3) the highest-return catalyst (mortgage normalization) is a cyclical option, not secular. Better than Equifax on organic pace and International quality — but without a Work Number–style annuity to guarantee the mix stays rich.

6. Financial Quality

The headline arc is a high-quality franchise whose reported returns are dragged below the cost of capital by 2021 acquisition accounting, while its cash economics inflect out of the trough. Revenue compounded from $2,960.2M (FY21) to $4,576.3M (FY25), but the important quality signal is the widening gap between GAAP and cash. GAAP operating margin FY25 was 18.9% (op income $864.6M); GAAP gross margin ~59%. Management and the Street run on Consolidated Adjusted EBITDA: FY25 $1,645.9M, a 36.0% margin — flat vs FY24, up from FY23’s 35.1% (FACT — 10-K MD&A p.65). The reconciliation from GAAP net income ($455.4M) adds back D&A $574.8M, net interest $202.6M, and taxes $173.1M (→ EBITDA $1,405.8M), then SBC $145.6M, accelerated technology investment $84.5M, operating-model-optimization $32.3M, M&A/divestiture $30.0M, and net other −$52.3M.

Quality-of-earnings — scrutinize the add-backs. Two deserve a skeptic’s eye. SBC ($145.6M) is a real, recurring economic cost — excluding it flatters the margin ~3.2 points and equals ~22% of true FCF. The “accelerated technology investment” ($84.5M) has run three straight years ($70.6M → $84.2M → $84.5M) and is partly capex-funded, so treating it as a one-time add-back is generous — it reads like ordinary tech spend re-badged. The optimization/restructuring add-backs (~$62M combined) are legitimate one-timers now that the transformation plan closed at end-2025. The largest, cleaner distortion is the FY23 $414.0M goodwill impairment — on the United Kingdom (Callcredit) reporting unit, NOT Neustar (FACT — 10-K MD&A footnote; balance-sheet Note). The 2021 U.S. acquisition goodwill has never been impaired — an important correction to a common assumption. Adjusted diluted EPS was $4.30 (+10%) vs GAAP diluted $2.32; the ~46% gap is driven mostly by acquired-intangible amortization ($290.2M pre-tax) — non-cash but real-economic-substance (capital already spent to buy customer relationships/technology).

Free cash flow — build it properly. ROIC.ai’s “free cash flow” field equals CFO and does not net capex, overstating FCF by ~$326M. True FCF (CFO − total capex):

(FACT — 10-K Statements of Cash Flows; capex ~7.1% of revenue.) FY22 CFO was artificially depressed ($297.2M) by a ~$454M working-capital outflow tied to the Neustar tax-payable reversal — not run-rate. The trend is genuinely improving as capex falls from 8% toward a guided ~6% of revenue and the transformation savings land. FCF conversion is climbing back toward management’s 90%+ target from the ~50% M&A-integration trough.

Returns on capital — the goodwill drag. Consolidated returns are mediocre: ROIC ~6.6%, ROE 17.9%, ROA 4.1% (FY25) (FACT — ROIC.ai). The 6.6% ROIC sits below a reasonable ~8–9% WACC — but this is a balance-sheet artifact of overpaying in 2021: goodwill + intangibles are ~75% of assets. On the ~$1.3B of tangible invested capital, the operating cash returns are exceptional. Economics clearly improve with scale at the operating level (incremental operating margin ~33%), but the consolidated return is dragged below WACC by the 2021 premium — the return is real, the price paid for it was not.

Balance sheet. Total debt $5,103.8M, cash $853.6M → Net Debt $4,250.2M (2.6x). All debt is floating-rate senior secured term loans (B-5 due Nov-2026 through B-9/A-4 to 2031) plus a $600M revolver — no fixed-rate notes — at a 5.42% weighted-average rate, 4.9-year average life, 75.5% swapped to fixed (up from 71.6%), materially blunting rate risk. Interest coverage (EBITDA/interest) is 6.1x (FY24 4.8x). Tangible book value is deeply negative, −$3.8B (equity ~$4.5B less ~$8.4B goodwill+intangibles) — normal for a serial acquirer, but it means equity holders sit behind a large intangible-funded debt load.

Verdict — do economics improve with scale? Yes at the unit level; not yet at the consolidated-return level. This is a high-margin, capital-light, cash-generative oligopoly business (36% adjusted-EBITDA margins, rising ~14.5% FCF margin, falling capex). But reported returns on the whole enterprise are sub-WACC because ~75% of the balance sheet is goodwill from the 2021 buying spree. The quality of the operating business is high; the quality of the returns to capital as invested is only average until the acquisitions are fully earned back — and SBC of ~$146M/yr is a real, recurring cost the headline strips out.

7. Capital Allocation

The 2021 M&A binge is the central test. In 2021 TransUnion deployed ~$3.7B of cash for acquisitions — anchored by Neustar (~$3.1B, Dec-2021), plus Sontiq and Argus — funded overwhelmingly with debt, taking gross leverage to ~6.3x at close (net ~4.4x). The strategic logic (marketing/identity data + fraud to broaden beyond core credit) is defensible, and — importantly — the U.S. acquisition goodwill has never been impaired, so the market-value case for “overpayment” is weaker than the leverage headline suggests. The one goodwill write-down ($414M, FY23) was the U.K. (Callcredit, a 2018 deal), a pre-existing/legacy problem, not the 2021 deals. The 2021 program was aggressive and richly priced (~27x EBITDA on Neustar) and consumed four years of balance-sheet flexibility — but the assets appear to be performing; the verdict is “expensive but not yet value-destroying,” pending evidence the Neustar cross-sell actually monetizes via OneTru (INTERPRETATION). The one clearly excellent decision of the era was the 2021 Healthcare divestiture ($1.735B, ~$982M gain) that helped fund the spree.

Deleveraging has been the clear, disciplined priority. Net-debt/adjusted-EBITDA fell from ~3.6x (FY23) → 3.0x (FY24) → 2.6x (FY25), on EBITDA growth plus steady term-loan prepayments ($250M in 2023, $150M in 2024) and refinancings that extended maturities and cut spreads. Only after crossing ~3x did management pivot to shareholder returns.

Dividends & buybacks. TRU pays a small, well-covered dividend (~$0.1155/quarter, ~$0.47/yr; $90.5M paid in FY25; ~19% of adjusted EPS; ~0.6% yield) — deliberately modest given the leverage. Buybacks were dormant 2021–24; the pivot came in 2025: the Board authorized a $500M program (Feb-2025), doubled it to $1.0B (Oct-2025), and the company repurchased ~$279.5M net in FY25 — the first meaningful buyback since the debt-financed M&A. Sensible sequencing (debt down first), but the ramp is new and unproven, and at ~18x adjusted EPS the shares are not obviously cheap on an absolute basis (though cheapest-ever on own history).

Reinvestment intensity. Capex is running down 8% → 7.1% (FY25) → guided ~6%, even as OneTru migration continues — peak build-out spend is rolling off, which should lift FCF. The transformation plan (approved Nov-2023, completed end-2025) targets ~$120–140M of annual run-rate savings.

Incentive alignment (2026 proxy). Short-term incentive metrics: Defined Adjusted EBITDA (35%), Defined Revenue (35%), Defined Adjusted Diluted EPS (30%); FY25 paid ~140–174% of target. Long-term PSUs: Cumulative Adjusted EBITDA, Cumulative Revenue, and Relative TSR (50% weight) over three years; FY25 rTSR landed at the 62nd percentile → 138% vesting (FACT — 2026 DEF 14A). The metric set is growth- and EBITDA-centric with a healthy 50% rTSR gate — reasonable, but it rewards revenue and adjusted EBITDA, which acquisitions inflate, and carries no explicit ROIC or FCF-per-share hurdle — a mild weakness given the 2021 leverage-funded deal history. Directors and executive officers as a group own just 716,417 shares (<1%); ownership is dominated by index holders (BlackRock 9.66%, Vanguard). Low insider ownership + adjusted-EBITDA-linked pay is a governance caution, not a red flag.

Verdict: a mixed but improving record. Management made one large, debt-fueled, top-of-cycle bet in 2021 that stretched the balance sheet and cost years of flexibility — but the acquired assets are so far performing (no U.S. impairment, segments growing), and the subsequent capital allocation (relentless deleveraging to 2.6x, then a disciplined dividend and a scaling buyback) has been textbook. The open question is whether the 2021 price is ever fully justified by OneTru monetization. Grade: average-to-good, trending better — but not yet vindicated.

8. Changes and Headwinds — Last Two Years

• Leadership: continuity, not transition. Chris (Christopher A.) Cartwright remains President & CEO (since May-2019); Todd Cello continues as EVP & CFO (since Aug-2017). No C-suite turnover. The Board expanded 10→12 seats, adding directors Sayan Chakraborty (ex-Workday) and Charlotte Yarkoni (ex-Microsoft) effective Jan-5-2026 — a tech/product governance refresh, thesis-neutral (FACT — 8-K 2025-12-23, Item 5.02).
• OneTru platform launch. OneTru — the AI/identity-resolution “solution enablement platform” centralizing data management and analytics — is the strategic integration vehicle for Neustar/legacy data assets, being rolled to credit, fraud, and marketing customers. It is the crux of the “did the 2021 M&A work?” question; monetization evidence is still early (FACT + INTERPRETATION).
• Transformation / cost program completed. The operating-model optimization plan (Board-approved Nov-2023) completed at end-2025, on track for ~$120–140M annual savings — a 2026 margin/FCF tailwind.
• Mortgage cycle + score-war. Financial Services grew +17.5% in FY25, with mortgage up “primarily on increased pricing” — revenue is price-led, not volume-led. Named forward risks: FICO’s Mortgage Direct License Program and GSE moves toward bi-merge (fewer than three bureau pulls per mortgage) — structural threats to the tri-merge pricing model, netted against TransUnion’s VantageScore ownership upside (FACT — 10-K risk factors).
• Deleveraging + refinancing milestones. Multiple 2024–25 term-loan repricings/extensions (B-8, B-9, A-4) plus prepayments took leverage to 2.6x; recurring 8-K Items 1.01/2.03 document the work.
• Capital-return pivot. $500M → $1.0B buyback authorization (2025); first material repurchases in years.
• Regulatory/litigation. No new headline CFPB enforcement action or material settlement surfaced in the trailing window; the CFPB/FTC supervisory overhang and standard FCRA litigation risk persist as ongoing (not acute) items. India’s DPDPA raises compliance cost at CIBIL.

Verdict: net thesis-strengthening. Deleveraging to 2.6x, the completed cost program, falling capex, and management continuity de-risk the story; the offsets (FICO mortgage-license threat, bi-merge risk, Consumer Interactive erosion, unproven OneTru monetization) are real but not yet impairing.

9. Risk Analysis

Overall: The dominant risks are cyclical (mortgage/lending volumes) and structural-but-contested (FICO/bi-merge), with a low-probability/very-high-impact breach tail. Leverage is a real but shrinking amplifier, not a solvency question. No single risk is thesis-ending; the cluster is what earns the discount.

10. Valuation Discussion

Where TransUnion trades (reference $78.31, 2026-07-02). On ~193M shares (~196.6M diluted), market capitalization is ~$15.1B. Adding total debt of ~$5.1B, subtracting $853.6M cash, and adding ~$106M minority interest gives an enterprise value of ~$19.7B (FACT — ROIC EV recomputed to the current reference price; ROIC’s headline $21.1B EV is struck at the higher FY25 year-end close). Against FY25 results and management’s non-GAAP figures (adjusted EBITDA $1,645.9M / 36.0%; adjusted diluted EPS $4.30):

Own-history context — the “cheapest-ever” tell. TransUnion sits at the bottom of its own decade: the AZI valuation-index own-history percentiles place TRU at the 7.2nd-percentile composite — with P/E at the 2.28th percentile (cheapest-ever), P/B (3.21x) at the 11.75th, and P/S (3.25x) at the 7.62nd (FACT — AZI valuation_index, 2026-07-02). The EV/EBITDA history confirms a genuine de-rate rather than a screen artifact: year-end GAAP EV/EBITDA ran 26.7x (FY21) → 14.2x (FY22 trough) → 17.8x (FY24) → 14.6x (FY25); at $78.31 the multiple is ~13.7x GAAP / ~12.0x adjusted — below every year of the decade except the 2022 crash trough. Price-to-tangible-book is negative every year (goodwill artifact), so reported P/B is the only usable balance-sheet multiple.

Peer comparison — TransUnion is the cheapest name in the complex.

(peer figures from public filings and market data.) TransUnion trades at the lowest EV/EBITDA of the entire data-analytics complex — roughly a turn below Equifax and ~5–9 turns below the ratings/index/insurance group. The discount to EFX is earned (levered #3, more cyclical, no crown jewel); the discount to the ratings cohort reflects thinner margins (~36% vs 50%+) and higher beta. But “earned discount” and “correctly priced” are not the same thing.

Embedded expectations / reverse-DCF. A simple reverse-DCF on the ~$19.7B EV — normalized unlevered FCF ~$950M, WACC ~8.5%, 3% terminal — implies the market is underwriting only ~3.5–4% perpetual growth (ASSUMPTION on inputs; INTERPRETATION on implied growth), well below TransUnion’s demonstrated high-single-digit organic framework and the +9.4% it just delivered. On the equity side, ~17–18x adjusted earnings for a business that can compound adjusted EPS at low-teens (high-single-digit revenue + margin expansion + deleveraging/buyback) is undemanding. What the market prices correctly: the levered #3 reality; ~2.6x leverage caps capital-return optionality and amplifies cyclicality; depressed mortgage volumes; India regulatory noise. What is more debatable: the triopoly’s structural economics are intact and margins have been expanding; the mortgage weakness is more plausibly cyclical than structural; and OneTru + deleveraging give a credible path to higher FCF conversion and a partial re-rate.

Scenario analysis (2-year / FY27 horizon — illustrative, no price target).

(ASSUMPTION on all inputs; illustrative, not a price target.) The bear case sits roughly at spot (~$71 vs $78) — the price already embeds a depressed, no-multiple-recovery outcome — the base (~$97, +24%) requires only in-framework growth at today’s multiple plus a little deleveraging, and the bull (~$127) needs a modest re-rate toward the EFX/Experian band on a mortgage turn. The asymmetry is positive, but ~2.6x leverage and a ~1.5–1.9 beta amplify both tails. No price target. No recommendation.

11. Variant Perception

Consensus belief. The market has re-cast TransUnion as the structurally disadvantaged #3 bureau — a levered, lower-margin, more-cyclical franchise without a crown jewel, whose growth is hostage to depressed mortgage/lending volumes, whose ~2.6x leverage and negative tangible book cap the quality rating, and whose India engine faces regulatory overhang. In this view the de-rate from ~27x to ~12x EV/EBITDA is a permanent correction to the company’s true, lower quality. Sell-side is Neutral with price targets $72–77 — essentially at spot — the tell of a name the Street has quietly given up on. The factor tape agrees: negative momentum, negative five-year Sharpe, traded as a high-beta lending cyclical.

Strongest bull case. TransUnion is one of three firms in a regulated, government-protected triopoly whose product is a non-substitutable input to every U.S. consumer-credit decision — the textbook Greenwald economies-of-scale-plus-captivity moat, visible in durable 30%+ EBITDA margins, annual pricing power, and a margin expanding toward 36% even through a weak-volume period. The mortgage depression is cyclical, not structural — a latent refi/origination pool re-converts to high-margin inquiry revenue the moment rates fall. OneTru removes cost and re-accelerates innovation; deleveraging from ~2.6x converts EBITDA growth into outsized equity FCF; and the feared FICO/VantageScore score-war is a tailwind to the data layer TransUnion owns. Bought at the 2.28th percentile of its own decade’s P/E and the cheapest EV/EBITDA in the complex, the price embeds almost none of this.

Strongest bear case. TransUnion is the #3 in a business where scale is the moat — squeezed between Experian (#1, premium) and Equifax (#2, with the dual-data Workforce crown jewel), with no comparable differentiated asset. Its ~2.6x leverage and negative tangible book (~$8.4B goodwill from top-of-cycle 2021 M&A) leave no cushion. Growth is cyclically geared to lending volumes that may stay depressed for years; the India jewel faces RBI/regulatory risk; and as a company that is its data it carries the same catastrophic-breach tail as Equifax’s 2017 event. “Cheap on its own history” is circular if the 2021 multiple was a bubble — reverting toward a deserved #3 discount implies limited upside, and the high beta means it re-breaks on any macro disappointment.

The 3–5 assumptions that matter most: (1) Is U.S. mortgage/lending weakness cyclical or structural? (2) Can the #3 hold pricing and share in a scale-driven triopoly — the margin trajectory (expanding vs eroding) is the proxy? (3) Does deleveraging + OneTru convert EBITDA growth into equity FCF? (4) Does the multiple re-rate off ~12x, or is the #3 discount permanent (25–40% of the base/bull case is multiple, not earnings)? (5) India — sustained mid-teens growth or regulatory disruption?

Falsification tests. Bull breaks if adjusted-EBITDA margin contracts over the next 2–3 quarters while U.S. Markets volume stalls (proving the #3 is being squeezed, not cyclically depressed), or if leverage fails to fall below ~2.5x. Bear breaks if organic revenue re-accelerates into a still-weak mortgage backdrop (proving the diversified lending/fraud/marketing/India engine drives it) and FCF conversion improves as OneTru costs roll off, validating a re-rate toward the EFX band.

Factor-positioning read. The tape corroborates abandonment, not crowding. TransUnion carries a negative momentum loading (Base −0.77), a high market beta (~1.6–1.9 model / 1.47 AZI), only a weak positive Quality tilt (+0.11), and a negative Growth tilt (−0.22) — the empirical fingerprint of an out-of-favor, high-beta cyclical, not a beloved compounder. Its dominant thematic loading is a custom “Financial Data Titans” basket (+1.05, R² 0.53) alongside factor-similar peers EFX, Gartner, Moody’s, S&P Global, RELX, and SS&C — confirming the data-analytics comp set. Risk-adjusted returns have been poor for years: 5-year −6.3%/yr (Sharpe −0.21), 10-year only +9.3%/yr with a −64.9% max drawdown, 1-year −12.6%. But the last quarter saw a violent ~+13% idiosyncratic rebound (m3 Sharpe 1.49) that just reclaimed the 200-day EMA — a chronically de-rated, abandoned name showing the first flicker of mean-reversion, consistent with a contrarian/value variant view while the negative momentum and high beta warn the reversal is nascent and unproven.

12. Fact vs. Interpretation

13. Open Questions

1. What is mortgage as an exact % of total revenue, decomposed into price vs volume? TransUnion does not disclose it cleanly; the FICO pass-through obscures the read. The FY26 segment detail is where the disruption thesis gets tested.
2. Does OneTru actually monetize the Neustar assets — i.e., is there segment-level evidence the 2021 M&A earns above its cost of capital, or does consolidated ROIC stay sub-WACC?
3. How fast, and to what magnitude, does FICO direct-licensing + any bi-merge shift compress bureau mortgage economics in reported results (vs the neutral-to-positive VantageScore offset)?
4. Does FCF conversion actually reach the guided 90%+ as capex falls to ~6% and OneTru costs roll off, or does “accelerated technology investment” persist as quasi-permanent opex?
5. Is India/CIBIL’s 2026 deceleration cyclical (subdued lending) or the start of regulatory/competitive pressure on the highest-quality growth engine?
6. Will management resist another large, leverage-funded acquisition now that the balance sheet has room, and execute the $1B buyback — or repeat the 2021 pattern?

14. What Must Be True

For the bull case (a re-rate toward the EFX/Experian band):

• Organic revenue holds high-single-digits into FY27 while mortgage stays weak — proving the diversified lending/fraud/marketing/India engine, not just mortgage, drives the growth.
• Adjusted-EBITDA margin holds/expands (36%→37%+) through the FICO pass-through drag, and FCF conversion climbs toward 90%+ as OneTru costs roll off.
• Leverage clears below 2.5x and the $1B buyback executes, converting EBITDA growth into per-share value.
• Falsification test: if the adjusted-EBITDA margin contracts for 2–3 quarters while U.S. Markets volume stalls, the “#3 is being squeezed” bear is proven and the bull is dead.

For the bear case (the #3 discount is permanent / deserved):

• FICO direct-licensing and/or a GSE bi-merge shift visibly compress bureau mortgage economics in FY26–27 reported segments, faster than the VantageScore offset.
• Consolidated ROIC stays below WACC as OneTru fails to monetize Neustar, and another large levered deal repeats the 2021 mistake.
• Growth proves to be mostly FICO pass-through + acquisition inflation once stripped, with organic drifting to low-single-digits.
• Falsification test: if organic revenue re-accelerates into a still-weak mortgage backdrop and FCF conversion rises, the structural-decline bear is falsified and the discount is revealed as cyclical mispricing.

15. Source Appendix

Primary sources — TransUnion FY2025 Form 10-K (filed 2026-02-27) and prior 10-Ks (FY21–24); Q1-2026 10-Q (2026-04-28) and FY25/FY24 quarterly filings; 2026 DEF 14A; the Form 4 corpus and material 8-Ks (2024–2026); the Q1-2026 earnings-call transcript — are catalogued in the standalone Appendix B — Source Appendix below. Quantitative cross-checks: ROIC.ai (statements, ratios, enterprise value), AZI (valuation-index own-history percentiles, price history), FactorsToday (factor loadings, risk-adjusted track record). Peer context: public filings and market data for EFX, Experian, FICO, SPGI, MCO, and VRSK. All third-party aggregated figures are reconciled to the filing; where ROIC.ai and the 10-K diverge, the filing governs.

APPENDIX A — Standard Diligence Questionnaire — TransUnion (NYSE: TRU)

Supplemental to the memo. Fact/Interpretation/Assumption labels where they matter. Report date 2026-07-04; price reference $78.31.

General

What thoughtful questions have other investors asked about this company? The sharpest cluster: (1) Does FICO’s Mortgage Direct License program structurally disintermediate the bureau markup? (2) How much of “mortgage growth” is real volume vs zero-margin FICO/score price pass-through? — the +24% reported vs +14% ex-FICO Financial Services split (Q1-26) is the data point skeptics return to. (3) If the moat is real, why has consolidated ROIC sat below the cost of capital for years? — the honest answer is 2021 acquisition accounting, which means the moat accrues to the asset, not cleanly to the shareholder. (4) What is the path back to 90%+ FCF conversion, and does OneTru actually monetize Neustar? (5) Is India/APAC softness cyclical or structural?

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Closer to a cyclical low/mid, not a high. U.S. mortgage origination volumes remain >50% below the 2015–19 norm; recent mortgage revenue strength is price/repricing, not a volume recovery, so the volume lever is still coiled. A rate-driven origination normalization is latent, high-margin upside TransUnion does not control (Fact on volumes; Interpretation on the coil).

Driven by external environment or internal actions? Predominantly external in the swing factors (rates, mortgage/lending volumes, consumer-credit health), with a meaningful internal overlay (the completed transformation program, OneTru migration, pricing, and M&A). The base data-services revenue is sticky and internally controllable; the incremental quarterly slope is macro-driven.

How stable are revenues? Moderately stable, more cyclical than peers. Recurring, embedded data-pull usage provides a high floor (revenue compounded from $1.5B in 2015 to $4.58B in 2025 through cycles), but TransUnion is the most U.S.-consumer-credit-concentrated of the three bureaus, giving it the highest cyclical beta (~1.5–1.9). Aggregate revenue is stable; the Financial Services/mortgage mix swings hard.

Outlook for products/services? Core credit data: durable, with pricing power, but facing feared (over-stated) score-layer competition in mortgage. Growth vectors: fraud/identity (TruValidate, ex-Neustar), marketing (TruAudience), OneTru AI-enabled analytics, Emerging Verticals (insurance, public sector, tenant/employment), and international (India/CIBIL). AI-monetization claims are management characterization not yet fully visible in segment margins.

How big is the market — growing/shrinking, domestic/international? The global credit-bureau and data-analytics market is large and structurally growing (digitization of lending, fraud, alternative data, open banking). TransUnion is ~78% U.S. / ~22% International by FY25 revenue, with India/CIBIL a rare #1 position in a large secular-growth credit economy. The legacy U.S. core faces volume maturity and mortgage-score price scrutiny; the growth is in international penetration and adjacencies.

Business Quality & Competitive Moat

More or less competitive industry? Structure intact, edge contested. The three-firm oligopoly is not challenged by new entrants (the data cooperative can’t be replicated), but the highest-margin mortgage-scoring niche now has FICO direct-licensing and VantageScore price competition — a shift toward price competition in one slice, netted by TransUnion’s one-third VantageScore ownership and retained tri-merge data pull.

How profitable — ROIC/ROE? Operationally very profitable (36.0% adjusted-EBITDA margin, 18.9% GAAP operating margin) but consolidated returns are subpar: ROIC ~6.6% (sub-WACC), ROE 17.9% — the gap is ~$8.4B of acquisition goodwill+intangibles. High margins on revenue, average returns on the capital as invested. On tangible invested capital (~$1.3B) the cash returns are exceptional (Fact on ratios; Interpretation on goodwill artifact).

How profitable is the industry? Barriers to entry? Highly profitable for incumbents (Experian ROE ~27% is the leader; Equifax mid-teens; TRU ~18% ROE). Only three national bureaus plus FICO at the score layer. Barriers are very high: reciprocal data-furnishing network, FCRA-compliance scale, and the tri-merge convention. A new national bureau is effectively impossible — which is why the bear case is about margin/price erosion within the oligopoly, not new entrants.

Can the business be easily understood? Mostly yes — collect lender-furnished data, sell it back as reports/scores at near-zero marginal cost. Complexity sits in the M&A-built adjacencies (Neustar identity/communications, marketing) and the FICO/VantageScore royalty mechanics.

Undermined by foreign low-cost labor? No. The moat is proprietary domestic data + regulatory embedding, not labor cost. Offshoring affects opex at the margin, not competitive position.

Do brands matter? Partially. On the B2B side (lenders, the real customers) data quality and the tri-merge requirement matter more than brand. On the B2C side (Consumer Interactive) brand/marketing matter more — and that line has been the locus of CFPB actions over deceptive marketing.

Nature of competition? Oligopolistic and historically rational (the three rarely price-compete on the core file). That rationality is being tested only in mortgage scoring, where the bureaus are cutting VantageScore pricing to win score-layer share.

Customer switching costs? High on the B2B core. Lenders are integrated into bureau data feeds, dispute systems, and underwriting workflows; for conforming mortgages the tri-merge convention historically required all three. The risk is a regulatory shift to bi-merge, which would mechanically remove one bureau’s pull per loan.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? Yes — the core point. TransUnion’s decades-deep, internally-generated consumer-credit database is largely not capitalized at anything near its economic value; the book carries acquired intangibles (Neustar, Callcredit) but the irreplaceable native credit file is effectively off-book. This is precisely why reported ROIC understates the asset-level economics — examine ROIC both with and without acquisition goodwill.

Off-balance-sheet liabilities? Standard operating leases and contractual obligations. The material “hidden” liability is contingent regulatory/litigation exposure (recurring CFPB/FTC matters) — episodic, hard to quantify ex ante. No evidence of aggressive off-balance-sheet financing.

How conservative is the accounting? Mixed — watch the adjustments. GAAP is clean, but the GAAP-to-adjusted gap is wide and recurring: acquired-intangible amortization ($290M), SBC ($145.6M, a real cost), and a persistent “accelerated technology investment” add-back (~$85M/yr for three years) that looks like ordinary tech spend re-badged. Treat adjusted EBITDA margin (36%) as real but adjusted EPS as partly flattered; anchor on true FCF.

How CapEx-hungry? Moderate and declining by design — capex from 8% → 7.1% (FY25) → guided ~6% of revenue. Not physically heavy, but meaningful capitalized software/technology spend (OneTru); the reduction target is meant to lift FCF.

Capital Allocation & Management

How much FCF, and how is it used? Philosophy? True FCF (CFO − capex) was $661.6M in FY25 (14.5% margin), up from $516.7M (FY24) and $334.7M (FY23) — rising as capex falls and transformation savings land. For most of the past decade FCF went to M&A and debt service; the 2025 pivot to a scaling buyback ($1B authorization) plus a modest dividend is a genuine, if unproven, shift toward shareholder return.

Significant recent acquisitions? A serial pattern: Callcredit (UK, $1.4B, 2018 — later impaired $414M), Neustar ($3.1B, 2021, ~27x EBITDA), Sontiq ($638M, 2021), Argus, Monevo (2025), and the pending TU Mexico majority stake. The 2021 Healthcare divestiture ($1.735B, ~$982M gain) was the best decision of the era. Continued M&A is itself a watch-item given the track record.

Buying back shares? Yes, but only recently — dormant 2021–24, restarted 2025 (~$279.5M net), authorization $500M → $1.0B (Oct-2025). Execution consistency is a “show-me.”

Large share issuance to insiders? No evidence of egregious dilution; share count relatively stable. Standard equity comp (SBC $145.6M/yr).

Compensation policy? Short-term incentives on Adjusted EBITDA (35%) / Revenue (35%) / Adjusted EPS (30%); long-term PSUs on cumulative EBITDA/revenue + 50% relative TSR. Reasonable, with a healthy rTSR gate — but growth/EBITDA-centric metrics that acquisitions inflate, and no explicit ROIC or FCF-per-share hurdle. Directors + officers own <1%.

Motivations of management? Cartwright (CEO since 2019) has pursued growth-by-acquisition-plus-transformation; the 2025 deleveraging + buyback pivot is shareholder-friendly. But insiders have logged zero open-market purchases (only routine grant/vest/sell) and own <1% — no conviction “tell” of undervaluation.

Valuation & Market Data

ADR? MLP? K-1? None. TransUnion is a Delaware C-corporation, common stock on the NYSE (TRU). It issues a 1099-DIV, not a K-1 — clean U.S. equity for tax purposes.

Dividend policy? Initiated at $0.075/quarter (2018), held flat through 2024, then raised to $0.115 (2025) and ~$0.1155 (recent) — ~$0.47/yr, ~0.6% yield, ~19% payout. A secondary capital-return tool behind debt paydown and buybacks.

How profitable? (Reprise.) High margins (36% adjusted EBITDA), average returns on capital (~6.6% ROIC vs ~8–9% WACC) — the defining tension.

Net income diverging from cash from operations? GAAP net income ($455.4M) is well below CFO ($987.6M) — the gap is D&A/amortization (non-cash) plus working capital. True FCF ($661.6M) is the cleaner signal; net income is depressed by acquired-intangible amortization, not by cash quality.

Risks & Downside

What would cause the stock to decline? In rough order: (1) FICO direct-licensing / bi-merge compressing mortgage-score economics faster than the VantageScore offset; (2) prolonged high rates keeping mortgage volumes depressed (latent EBITDA never converts); (3) a U.S. consumer-credit downturn cutting inquiry volumes; (4) another large, expensive, leverage-funded acquisition; (5) a CFPB/FTC enforcement action or adverse FCRA class action; (6) FCF conversion stalling / OneTru monetization failing; (7) India/CIBIL regulatory disruption.

Risk of catastrophic loss? Low-to-moderate, with one real tail: a major cybersecurity/data breach. TransUnion holds sensitive data on essentially every U.S. adult; Equifax’s 2017 breach showed a single incident can inflict billions in cost and lasting damage. That is the most credible path to a step-change permanent loss.

Chance of total loss? Very low. An investment-grade-adjacent, cash-generative, structurally entrenched oligopolist with ~$5.1B debt against ~$1.65B EBITDA (~2.6x) is not a zero candidate. Total loss would require a simultaneous catastrophic breach, regulatory destruction of the bureau model, and refinancing failure — possible in theory, remote in practice.

Recent News & Events

Has the business environment changed recently? Materially — the FICO/VantageScore score-war is the headline change. FICO’s Oct-2025 Mortgage Direct License program and the FHFA’s Jul-2025 VantageScore 4.0 approval introduced price/margin competition into the mortgage-scoring niche — feared by the market as disruption, but on balance a tailwind to the bureaus’ protected data layer (they own the rival score and keep the tri-merge pull). Separately, the transformation cost program completed at end-2025 and the capital-return pivot (buyback to $1B) began.

Significant recent acquisitions? Monevo (2025), the pending TU Mexico majority stake (~$154M to the guide high end), and the Dec-2025 RealNetworks mobile-AI deal. The continued M&A cadence is a watch-item.

Recently changed accounting policies? No material policy change. The relevant caution is the persistent, wide GAAP-to-adjusted reconciliation, not a discrete policy shift.

Other recent changes? No CEO/CFO change (Cartwright CEO since 2019; Cello CFO since 2017). Board expanded 10→12 with two tech/AI directors (eff. Jan-2026). Q1-26 beat (+11% organic) with FY26 guidance held/raised toward $5.1–5.135B, a beat-and-hold posture the market punished at Equifax.

APPENDIX B — Source Appendix — TransUnion (NYSE: TRU)

Report date 2026-07-04. Public primary sources first. All third-party aggregated data reconciled to filings; where sources diverge on a material number, the SEC filing governs. Accessed 2026-07-04 unless noted.

Primary — SEC Filings (EDGAR, CIK 0001552033)

Primary — Transcripts

Quantitative Data Services (third-party; reconciled to filings)

Peer / Cross-read (public data)

Comparative multiples and industry framing for the credit-bureau and data-analytics complex — Equifax (EFX), Experian (EXPN.L), FICO, S&P Global (SPGI), Moody’s (MCO), and Verisk (VRSK) — drawn from those companies’ public filings and market data.

Notes on Reconciliation

• Adjusted vs GAAP: FY25 adjusted diluted EPS $4.30 vs GAAP $2.32; the ~46% gap is mostly acquired-intangible amortization ($290.2M pre-tax). Adjusted EBITDA $1,645.9M (36.0%) per the 10-K reconciliation.
• FCF: ROIC.ai’s “free cash flow” field equals CFO and does not net capex; true FCF (CFO − capex) = $661.6M FY25. FY22 CFO was distorted by a ~$454M Neustar-tax working-capital swing — not run-rate.
• Enterprise value: ROIC’s headline EV (~$21.1B) is struck at the FY25 year-end close ($85.75); recomputed to the $78.31 reference price, EV is ~$19.7B.
• Impairment: the FY23 $414M goodwill write-down was the U.K. (Callcredit) reporting unit — the 2021 U.S. acquisition goodwill has never been impaired.